These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 33050066)

  • 41. Metabolism-mediated drug interaction potential of HS-23, a new herbal drug for the treatment of sepsis in human hepatocytes and liver microsomes.
    Jeong HU; Lee JY; Kwon SS; Kim JH; Kim YM; Hong SW; Yeon SH; Lee SM; Cho YY; Lee HS
    Arch Pharm Res; 2015 Feb; 38(2):171-7. PubMed ID: 25052959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of an ethanol extract of Descurainia sophia seeds on Phase I and II drug metabolizing enzymes and P-glycoprotein activity in vitro.
    Yi JM; Kim YA; Lee YJ; Bang OS; Kim NS
    BMC Complement Altern Med; 2015 Dec; 15():441. PubMed ID: 26683337
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction of irinotecan (CPT-11) and its active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38) with human cytochrome P450 enzymes.
    Hanioka N; Ozawa S; Jinno H; Tanaka-Kagawa T; Nishimura T; Ando M; Sawada Ji J
    Drug Metab Dispos; 2002 Apr; 30(4):391-6. PubMed ID: 11901092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of Transporters Involved in Beraprost Sodium Transport In Vitro.
    Oshida K; Shimamura M; Seya K; Ando A; Miyamoto Y
    Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):117-128. PubMed ID: 26961540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major Drug-Metabolizing Enzymes or Transporters.
    Bleasby K; Houle R; Hafey M; Lin M; Guo J; Lu B; Sanchez RI; Fillgrove KL
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452431
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ciprofol is primarily glucuronidated by UGT1A9 and predicted not to cause drug-drug interactions with typical substrates of CYP1A2, CYP2B6, and CYP2C19.
    Hou L; Zhao Y; Zhao S; Zhang X; Yao X; Yang J; Wang Z; Chan ECY; Liu S
    Chem Biol Interact; 2024 Jan; 387():110811. PubMed ID: 37993078
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibitory effects of azelastine and its metabolites on drug oxidation catalyzed by human cytochrome P-450 enzymes.
    Nakajima M; Ohyama K; Nakamura S; Shimada N; Yamazaki H; Yokoi T
    Drug Metab Dispos; 1999 Jul; 27(7):792-7. PubMed ID: 10383922
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Charactering the metabolism of cryptotanshinone by human P450 enzymes and uridine diphosphate glucuronosyltransferases in vitro.
    Zeng J; Fan YJ; Tan B; Su HZ; Li Y; Zhang LL; Jiang J; Qiu FR
    Acta Pharmacol Sin; 2018 Aug; 39(8):1393-1404. PubMed ID: 29417949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions.
    Micuda S; Mundlova L; Anzenbacherova E; Anzenbacher P; Chladek J; Fuksa L; Martinkova J
    Eur J Clin Pharmacol; 2004 Oct; 60(8):583-9. PubMed ID: 15378224
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions.
    Katoh M; Nakajima M; Shimada N; Yamazaki H; Yokoi T
    Eur J Clin Pharmacol; 2000; 55(11-12):843-52. PubMed ID: 10805063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro drug-drug interactions of budesonide: inhibition and induction of transporters and cytochrome P450 enzymes.
    Chen N; Cui D; Wang Q; Wen Z; Finkelman RD; Welty D
    Xenobiotica; 2018 Jun; 48(6):637-646. PubMed ID: 28730856
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions.
    Ohyama K; Nakajima M; Suzuki M; Shimada N; Yamazaki H; Yokoi T
    Br J Clin Pharmacol; 2000 Mar; 49(3):244-53. PubMed ID: 10718780
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of the Drug Interaction Potential of Unconjugated and GalNAc
    Shemesh CS; Yu RZ; Warren MS; Liu M; Jahic M; Nichols B; Post N; Lin S; Norris DA; Hurh E; Huang J; Watanabe T; Henry SP; Wang Y
    Mol Ther Nucleic Acids; 2017 Dec; 9():34-47. PubMed ID: 29246313
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis).
    Albassam AA; Markowitz JS
    Planta Med; 2017 Apr; 83(6):496-508. PubMed ID: 28118673
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.
    Haque AKMM; Leong KH; Lo YL; Awang K; Nagoor NH
    Phytomedicine; 2017 Jul; 31():1-9. PubMed ID: 28606510
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of Herbal Formulas Bojungikgi-tang and Palmijihwang-hwan on Inflammation in RAW 264.7 Cells and the Activities of Drug-Metabolizing Enzymes in Human Hepatic Microsomes.
    Jin SE; Ha H; Shin HK
    J Med Food; 2018 Nov; 21(11):1173-1187. PubMed ID: 30457473
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    Bleasby K; Fillgrove KL; Houle R; Lu B; Palamanda J; Newton DJ; Lin M; Chan GH; Sanchez RI
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745395
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative Atlas of Cytochrome P450, UDP-Glucuronosyltransferase, and Transporter Proteins in Jejunum of Morbidly Obese Subjects.
    Miyauchi E; Tachikawa M; Declèves X; Uchida Y; Bouillot JL; Poitou C; Oppert JM; Mouly S; Bergmann JF; Terasaki T; Scherrmann JM; Lloret-Linares C
    Mol Pharm; 2016 Aug; 13(8):2631-40. PubMed ID: 27347605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of human drug metabolizing cytochrome P450 by buprenorphine.
    Umehara K; Shimokawa Y; Miyamoto G
    Biol Pharm Bull; 2002 May; 25(5):682-5. PubMed ID: 12033517
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the transporter-mediated herb-drug interaction potential of DA-9801, a standardized dioscorea extract for diabetic neuropathy, in human in vitro and rat in vivo.
    Song IS; Kong TY; Jeong HU; Kim EN; Kwon SS; Kang HE; Choi SZ; Son M; Lee HS
    BMC Complement Altern Med; 2014 Jul; 14():251. PubMed ID: 25034211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.